CORT — CORCEPT THERAPEUTICS INC

Ownership history in CASTLEARK MANAGEMENT LLC  ·  3 quarters on record

This page tracks every 13F SEC filing in which CASTLEARK MANAGEMENT LLC reported a position in CORCEPT THERAPEUTICS INC (CORT). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.11% (2017 Q3)
Avg. % of fund
0.07%
First filed
2017 Q3
Last filed
2025 Q3
Quarters held
3
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 REDUCED 2,740 -34,200 -92.6% 0.01% $228K $83.11
2025 Q2 REDUCED 36,940 -145,312 -79.7% 0.08% $2.7M $73.40
2017 Q3 INITIATED 182,252 — — 0.11% $3.5M —
% of Fund (quarterly)    CORT price (monthly, adj. close)

Other funds also holding CORT

As of 2025 Q4 — sorted by position size

INGALLS & SNYDER LLC 3Y 7Y 9.19% TANAKA CAPITAL MANAGEMENT INC 3Y 7Y 7.05% Checkpoint Capital L.P. 4.36% Parallel Advisors, LLC 3Y 7Y 2.47% Checkpoint Capital L.P. 1.39% Birchview Capital, LP 3Y 7Y 1.37% S&T BANK/PA 3Y 7Y 1.03% Intrinsic Edge Capital Management LLC 3Y 7Y 0.86% Newtyn Management, LLC 3Y 7Y 0.73% FAS Wealth Partners, Inc. 3Y 7Y 0.7%
← Back to CASTLEARK MANAGEMENT LLC Holdings